News Releases

November 13, 2017
Synlogic Reports Third Quarter 2017 Financial Results and Recent Progress
November 8, 2017
Synlogic to Present at Upcoming Investor Conferences in November
November 8, 2017
Synlogic Reports Positive Top-Line Phase 1 Data Demonstrating Safety and Tolerability and Proof of Mechanism in Healthy Volunteers for SYNB1020, a Synthetic BioticTM Medicine for the Treatment of Hyperammonemia
October 24, 2017
Synlogic Receives Orphan Drug Designation for SYNB1618, a Synthetic BioticTM Medicine for the Treatment of Phenylketonuria
October 10, 2017
Synlogic Strengthens Leadership Team with Appointment of Chief Operating Officer and Chief Human Resources Officer
September 20, 2017
Synlogic to Webcast Presentation at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
September 7, 2017
Synlogic Presents New Preclinical Data at International Congress of Inborn Errors of Metabolism
September 1, 2017
Synlogic to Webcast Presentation at BioCentury’s 24th Annual NewsMakers in the Biotech Industry Conference
August 28, 2017
Synlogic Completes Merger with Mirna Therapeutics
June 26, 2017
Synlogic Receives Fast Track Designation in U.S. for Lead Candidate, SYNB1020
June 19, 2017
Synlogic™ Doses First Subject in Phase 1 Trial of Novel Class of Synthetic Biotic™ Medicines
June 7, 2017
Synlogic Meets First Discovery Milestone in Partnership with AbbVie
Displaying 193 - 204 of 222